Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (578)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
159
2024
2918
11.480
Why?
Antibodies, Monoclonal
26
2024
459
6.360
Why?
Hematopoietic Stem Cell Transplantation
28
2024
556
3.460
Why?
Antineoplastic Agents
18
2024
1173
3.360
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
993
3.340
Why?
Humans
210
2024
49863
2.240
Why?
Thalidomide
24
2024
377
2.030
Why?
Monoclonal Gammopathy of Undetermined Significance
10
2024
111
1.930
Why?
Neoplasm Recurrence, Local
15
2024
627
1.830
Why?
Immunotherapy, Adoptive
9
2024
157
1.810
Why?
Killer Cells, Natural
8
2024
107
1.780
Why?
Transplantation, Autologous
26
2024
463
1.770
Why?
Interleukin-6
12
2023
265
1.680
Why?
Neoplasm Proteins
13
2022
322
1.610
Why?
Hematologic Neoplasms
3
2022
98
1.600
Why?
Middle Aged
72
2024
12258
1.480
Why?
Antigens, Neoplasm
6
2014
151
1.450
Why?
Clinical Trials as Topic
13
2022
463
1.440
Why?
Stem Cell Transplantation
10
2022
176
1.380
Why?
Prognosis
45
2024
1948
1.330
Why?
Gene Expression Regulation, Neoplastic
20
2022
822
1.290
Why?
Aged
72
2024
9434
1.280
Why?
Combined Modality Therapy
19
2024
638
1.260
Why?
Chromosomes, Human, Pair 1
9
2023
92
1.260
Why?
Herpesvirus 8, Human
7
2021
95
1.220
Why?
Translocation, Genetic
10
2022
263
1.190
Why?
Treatment Outcome
47
2024
5165
1.150
Why?
B-Cell Maturation Antigen
8
2024
87
1.140
Why?
Boronic Acids
12
2013
182
1.120
Why?
Pyrazines
12
2013
187
1.120
Why?
Male
82
2024
25439
1.110
Why?
Adult
52
2024
13325
1.110
Why?
Female
84
2024
26520
1.100
Why?
Bone Marrow
18
2024
352
1.070
Why?
Proteasome Inhibitors
5
2024
104
1.060
Why?
Antibodies, Bispecific
5
2024
70
1.020
Why?
Immunotherapy
6
2024
237
1.000
Why?
Gene Expression Profiling
26
2023
1029
1.000
Why?
Neoplasms, Second Primary
2
2024
74
0.990
Why?
Disease-Free Survival
24
2019
452
0.950
Why?
B-Lymphocytes
5
2024
175
0.930
Why?
Dexamethasone
14
2024
424
0.920
Why?
T-Lymphocytes, Cytotoxic
4
2014
65
0.900
Why?
Melphalan
9
2020
174
0.890
Why?
Cancer Vaccines
3
2010
78
0.880
Why?
Follow-Up Studies
26
2024
2174
0.870
Why?
Plasma Cells
11
2023
221
0.850
Why?
Hyperhidrosis
1
2022
2
0.840
Why?
Sweat
1
2022
7
0.830
Why?
Survival Rate
24
2020
904
0.810
Why?
Lymphoma, B-Cell
3
2022
61
0.800
Why?
Drug Approval
1
2022
47
0.790
Why?
Ehrlichia chaffeensis
1
2021
4
0.760
Why?
Patient Participation
1
2022
67
0.760
Why?
Ehrlichiosis
1
2021
14
0.750
Why?
T-Lymphocytes
8
2024
330
0.750
Why?
Cryosurgery
1
2021
35
0.750
Why?
Immunoglobulin Light Chains
3
2017
82
0.740
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
26
0.730
Why?
Embolization, Therapeutic
1
2021
85
0.710
Why?
Cell Proliferation
10
2023
999
0.690
Why?
Disease Progression
16
2023
822
0.680
Why?
Chromosomal Instability
1
2019
16
0.670
Why?
Membrane Proteins
3
2006
347
0.660
Why?
Neoplasms, Plasma Cell
3
2024
35
0.660
Why?
Survival Analysis
18
2024
669
0.650
Why?
Adrenal Cortex Hormones
2
2023
100
0.650
Why?
Immunologic Factors
2
2018
113
0.630
Why?
Epigenesis, Genetic
4
2023
369
0.620
Why?
Neoplasm, Residual
8
2022
158
0.620
Why?
Tumor Microenvironment
6
2024
221
0.620
Why?
Chromosome Aberrations
12
2023
295
0.610
Why?
Atrial Fibrillation
2
2022
182
0.600
Why?
POEMS Syndrome
1
2018
31
0.600
Why?
Dendritic Cells
3
2014
133
0.600
Why?
Thyroid Neoplasms
1
2019
111
0.580
Why?
Polymorphism, Single Nucleotide
3
2024
483
0.580
Why?
Prealbumin
2
2014
20
0.580
Why?
Antibodies, Monoclonal, Humanized
6
2023
225
0.560
Why?
Positron-Emission Tomography
7
2022
288
0.550
Why?
Receptors, Interleukin-6
2
2014
22
0.550
Why?
Cardiomyopathies
2
2014
114
0.520
Why?
Mutation
10
2022
1290
0.510
Why?
Aged, 80 and over
19
2024
3132
0.500
Why?
Osteolysis
4
2022
75
0.490
Why?
Immunotoxins
1
2014
6
0.470
Why?
Drug Resistance, Neoplasm
7
2024
313
0.470
Why?
Recurrence
13
2024
658
0.460
Why?
Cytotoxicity, Immunologic
2
2012
56
0.460
Why?
Clonal Evolution
3
2020
56
0.450
Why?
Practice Guidelines as Topic
4
2023
454
0.450
Why?
Cyclophosphamide
5
2021
163
0.440
Why?
Risk Factors
19
2024
3597
0.440
Why?
Transplantation, Homologous
5
2017
138
0.430
Why?
Amyloidosis
1
2014
77
0.430
Why?
Health Status
1
2015
298
0.430
Why?
Fluorodeoxyglucose F18
6
2021
191
0.410
Why?
Genome-Wide Association Study
3
2024
163
0.400
Why?
Remission Induction
13
2021
206
0.400
Why?
Neutropenia
2
2023
114
0.400
Why?
Receptors, KIR
2
2008
13
0.390
Why?
Genetic Predisposition to Disease
3
2024
507
0.380
Why?
Bone Diseases
3
2021
97
0.380
Why?
Dose-Response Relationship, Drug
8
2020
1354
0.380
Why?
Pyrimidines
2
2022
193
0.380
Why?
Thrombocytopenia
2
2022
79
0.370
Why?
Azacitidine
1
2010
34
0.370
Why?
Benzamides
1
2010
50
0.360
Why?
Evolution, Molecular
2
2021
97
0.360
Why?
Histone Deacetylase Inhibitors
1
2010
56
0.360
Why?
C-Reactive Protein
6
2022
143
0.350
Why?
Prednisone
2
2021
100
0.350
Why?
Doxorubicin
6
2021
233
0.350
Why?
TOR Serine-Threonine Kinases
2
2020
76
0.330
Why?
Drug Administration Schedule
5
2015
370
0.330
Why?
Chromosome Deletion
5
2023
137
0.330
Why?
Metaphase
4
2016
44
0.330
Why?
Pelvis
2
2021
66
0.330
Why?
Vaccination
4
2022
275
0.320
Why?
Quality of Life
1
2015
837
0.320
Why?
Membrane Glycoproteins
2
2009
247
0.320
Why?
Paraproteinemias
3
2022
71
0.310
Why?
Animals
15
2024
13133
0.310
Why?
Proportional Hazards Models
7
2024
404
0.310
Why?
Placebo Effect
2
2020
16
0.300
Why?
Bone Neoplasms
4
2013
179
0.300
Why?
Adoptive Transfer
1
2007
40
0.300
Why?
Histocompatibility Antigens Class I
1
2007
44
0.290
Why?
Chromatin
3
2023
134
0.290
Why?
CD8-Positive T-Lymphocytes
3
2024
123
0.290
Why?
Cytogenetic Analysis
5
2023
80
0.290
Why?
DNA Methylation
4
2023
544
0.280
Why?
Boron Compounds
2
2024
19
0.280
Why?
Risk Assessment
9
2022
1253
0.280
Why?
Chromans
2
2024
35
0.280
Why?
Vincristine
3
2021
84
0.280
Why?
Mice, SCID
6
2013
173
0.270
Why?
Cell Membrane
1
2007
251
0.270
Why?
Glycine
2
2024
75
0.270
Why?
Down-Regulation
1
2007
347
0.270
Why?
Angiogenesis Inhibitors
5
2010
187
0.270
Why?
In Situ Hybridization, Fluorescence
5
2023
256
0.270
Why?
Neoplasm Staging
6
2024
748
0.260
Why?
Cell Line, Tumor
9
2023
1387
0.260
Why?
Disease Management
2
2018
175
0.260
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.260
Why?
Vitamin E
2
2024
76
0.250
Why?
Transplantation Conditioning
5
2008
82
0.250
Why?
Case-Control Studies
6
2024
1129
0.250
Why?
Mice
11
2024
5671
0.250
Why?
Infusions, Intravenous
3
2015
212
0.250
Why?
Bone Resorption
2
2022
297
0.250
Why?
Antibody Formation
1
2005
51
0.240
Why?
Fever
2
2022
110
0.240
Why?
Registries
3
2024
522
0.240
Why?
Polycomb Repressive Complex 2
2
2021
46
0.240
Why?
Time Factors
11
2021
2889
0.230
Why?
Flow Cytometry
4
2012
473
0.230
Why?
Monocytes
2
2020
131
0.230
Why?
Gene Expression
2
2018
613
0.230
Why?
High-Throughput Nucleotide Sequencing
3
2022
169
0.220
Why?
Ubiquitin-Protein Ligases
1
2024
94
0.220
Why?
Cell Cycle Proteins
2
2022
163
0.220
Why?
Blotting, Western
3
2015
600
0.220
Why?
Proteasome Endopeptidase Complex
3
2011
116
0.220
Why?
Signal Transduction
6
2021
1605
0.220
Why?
Epstein-Barr Virus Infections
2
2020
29
0.220
Why?
Radiation-Protective Agents
1
2024
72
0.220
Why?
Integrin beta Chains
1
2023
13
0.220
Why?
Prospective Studies
8
2022
2341
0.220
Why?
Integrins
1
2023
30
0.210
Why?
Double-Blind Method
2
2015
678
0.210
Why?
Young Adult
5
2020
4013
0.210
Why?
Cross-Sectional Studies
3
2023
1568
0.210
Why?
Sweating
1
2022
7
0.210
Why?
Hematopoietic Stem Cells
2
2022
182
0.210
Why?
Proto-Oncogene Proteins B-raf
2
2020
79
0.200
Why?
Consensus
2
2020
156
0.200
Why?
Proteomics
3
2021
293
0.200
Why?
DNA, Intergenic
1
2022
7
0.200
Why?
Kaplan-Meier Estimate
10
2016
463
0.200
Why?
Tumor Cells, Cultured
4
2013
460
0.200
Why?
Receptors, Antigen, T-Cell
1
2022
49
0.200
Why?
Tumor Suppressor Protein p53
2
2017
214
0.200
Why?
Immunoconjugates
1
2022
38
0.200
Why?
United States
4
2022
4870
0.200
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.200
Why?
United States Food and Drug Administration
1
2022
91
0.200
Why?
Influenza, Human
1
2022
83
0.190
Why?
Epigenomics
1
2021
67
0.190
Why?
Mediastinum
1
2021
20
0.190
Why?
Chromosomes, Human, Pair 14
3
2020
75
0.190
Why?
Receptors, Glucocorticoid
2
2012
32
0.190
Why?
Phosphatidylinositol 3-Kinases
2
2019
139
0.190
Why?
Ubiquitination
1
2021
40
0.190
Why?
Axilla
1
2021
89
0.190
Why?
Apoptosis
5
2018
1102
0.190
Why?
Alleles
3
2021
251
0.190
Why?
Multiple Organ Failure
1
2021
47
0.190
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
84
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
103
0.180
Why?
Salvage Therapy
6
2013
136
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
124
0.180
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.180
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.180
Why?
Rare Diseases
1
2020
44
0.180
Why?
Interferon-gamma
3
2014
176
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Longitudinal Studies
5
2024
693
0.180
Why?
Radiopharmaceuticals
4
2021
205
0.180
Why?
Cell Cycle
1
2021
225
0.180
Why?
Cytokines
2
2014
612
0.180
Why?
Interferon Type I
1
2020
24
0.170
Why?
Myelodysplastic Syndromes
2
2013
79
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
33
0.170
Why?
Research Design
2
2020
343
0.170
Why?
Multivariate Analysis
8
2021
577
0.170
Why?
Gene Amplification
1
2019
57
0.170
Why?
Health Status Disparities
1
2022
196
0.170
Why?
Genomics
4
2023
284
0.170
Why?
Measles virus
1
2019
8
0.170
Why?
Measles
1
2019
7
0.170
Why?
Gene Regulatory Networks
1
2020
107
0.170
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
Why?
DNA
1
2023
539
0.170
Why?
Data Collection
1
2020
283
0.170
Why?
Oncolytic Virotherapy
1
2019
18
0.170
Why?
Immunohistochemistry
2
2015
983
0.160
Why?
Biopsy
5
2018
591
0.160
Why?
Patient Safety
1
2020
102
0.160
Why?
Sirolimus
1
2019
62
0.160
Why?
Healthcare Disparities
1
2022
277
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Cell Differentiation
6
2022
651
0.160
Why?
Precancerous Conditions
2
2010
83
0.160
Why?
Proto-Oncogene Proteins c-akt
1
2019
156
0.160
Why?
Evidence-Based Medicine
2
2018
247
0.160
Why?
Syndrome
1
2019
237
0.160
Why?
Graft vs Host Disease
4
2007
73
0.160
Why?
MafB Transcription Factor
1
2018
9
0.160
Why?
Spleen
1
2019
170
0.160
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Genomic Instability
2
2016
91
0.150
Why?
Immunomodulation
1
2018
37
0.150
Why?
Plasma
1
2018
41
0.150
Why?
Chemokines
1
2018
78
0.150
Why?
Myeloablative Agonists
2
2008
30
0.150
Why?
Hematopoietic Stem Cell Mobilization
2
2008
56
0.150
Why?
Genes, Neoplasm
2
2015
30
0.150
Why?
Adipocytes
1
2018
121
0.150
Why?
Osteoclasts
3
2022
424
0.150
Why?
Magnetic Resonance Imaging
5
2013
1526
0.150
Why?
Models, Biological
2
2018
722
0.150
Why?
Gene Dosage
2
2015
78
0.150
Why?
Gene Rearrangement
1
2018
73
0.150
Why?
Hexokinase
1
2017
17
0.140
Why?
Communication
1
2019
246
0.140
Why?
Heterozygote
2
2014
80
0.140
Why?
HLA-A Antigens
2
2007
10
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Protein-Tyrosine Kinases
2
2018
93
0.140
Why?
Drug Therapy, Combination
1
2018
380
0.140
Why?
Retrospective Studies
8
2024
6106
0.140
Why?
Oligonucleotide Array Sequence Analysis
5
2010
410
0.130
Why?
Gene Frequency
2
2013
96
0.130
Why?
Transcriptome
4
2020
313
0.130
Why?
Syndecan-1
4
2021
72
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
178
0.130
Why?
Lymphocyte Activation
2
2017
171
0.130
Why?
Critical Illness
1
2018
295
0.130
Why?
Confidence Intervals
2
2014
155
0.130
Why?
Tumor Burden
3
2020
131
0.130
Why?
Adolescent
5
2020
6392
0.130
Why?
Erythrocyte Indices
1
2015
7
0.130
Why?
Biomarkers, Pharmacological
2
2012
25
0.130
Why?
Immunity, Innate
1
2016
106
0.130
Why?
DNA Copy Number Variations
3
2022
108
0.130
Why?
Coculture Techniques
2
2013
145
0.120
Why?
Hemoglobins
2
2013
105
0.120
Why?
Cysteine-Rich Protein 61
1
2014
3
0.120
Why?
International Cooperation
1
2014
44
0.120
Why?
Hematologic Diseases
1
2014
21
0.120
Why?
Half-Life
1
2014
86
0.120
Why?
Fatigue
1
2015
118
0.120
Why?
Iron
1
2015
123
0.120
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
244
0.120
Why?
Area Under Curve
1
2014
178
0.120
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Antibodies
2
2024
152
0.110
Why?
Reference Values
1
2014
302
0.110
Why?
ROC Curve
1
2014
224
0.110
Why?
Emotions
1
2015
166
0.110
Why?
Severity of Illness Index
2
2014
953
0.110
Why?
Renal Insufficiency
2
2021
107
0.110
Why?
Antineoplastic Agents, Alkylating
3
2008
74
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.110
Why?
Disease Models, Animal
2
2016
1448
0.110
Why?
Administration, Metronomic
1
2013
7
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Inflammation Mediators
1
2014
110
0.110
Why?
Cisplatin
4
2013
275
0.110
Why?
Macaca mulatta
2
2024
92
0.110
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
5
0.110
Why?
Central Nervous System Neoplasms
1
2013
64
0.110
Why?
beta Catenin
1
2013
101
0.110
Why?
Lymph Nodes
3
2021
261
0.110
Why?
Venous Thrombosis
2
2004
89
0.110
Why?
Oligopeptides
1
2013
93
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.100
Why?
Leukemia
1
2013
64
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Mental Health
1
2015
218
0.100
Why?
Cell Survival
2
2020
590
0.100
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.100
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.100
Why?
Clone Cells
2
2023
78
0.100
Why?
Maintenance Chemotherapy
1
2012
49
0.100
Why?
Pain
1
2015
374
0.100
Why?
Adaptor Proteins, Signal Transducing
2
2024
197
0.100
Why?
Vascular Endothelial Growth Factor A
1
2013
201
0.100
Why?
Models, Genetic
2
2016
170
0.100
Why?
Interleukin-2
1
2012
72
0.100
Why?
Cell Movement
1
2013
245
0.100
Why?
Mice, Inbred NOD
1
2012
94
0.100
Why?
Immunoenzyme Techniques
1
2012
144
0.100
Why?
Hemangioma
1
2013
83
0.100
Why?
Soft Tissue Neoplasms
1
2012
55
0.100
Why?
Genotype
1
2013
534
0.100
Why?
Arkansas
5
2021
1982
0.100
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
45
0.090
Why?
Chemokine CXCL13
2
2022
5
0.090
Why?
Models, Statistical
2
2014
223
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
53
0.090
Why?
Mutation Rate
2
2021
36
0.090
Why?
Immunoglobulin Idiotypes
1
2010
5
0.090
Why?
CD40 Ligand
1
2010
14
0.090
Why?
Hypersensitivity, Delayed
1
2010
21
0.090
Why?
Secondary Prevention
1
2010
78
0.090
Why?
Interleukin-4
1
2010
44
0.090
Why?
Up-Regulation
4
2018
448
0.090
Why?
HIV Seropositivity
1
2010
27
0.090
Why?
Eukaryotic Initiation Factor-2
1
2010
16
0.090
Why?
Immunity, Cellular
1
2010
69
0.090
Why?
Adjuvants, Immunologic
1
2010
51
0.090
Why?
Cell Line
2
2013
1012
0.090
Why?
Cells, Cultured
3
2013
1579
0.090
Why?
Etoposide
2
2007
72
0.080
Why?
Ovarian Neoplasms
1
2014
450
0.080
Why?
Placenta
1
2011
127
0.080
Why?
Transplantation, Heterologous
1
2009
75
0.080
Why?
Radiography
4
2012
485
0.080
Why?
Histones
2
2021
293
0.080
Why?
Hospitalization
2
2024
663
0.080
Why?
Polymerase Chain Reaction
1
2010
453
0.080
Why?
Cytotoxicity Tests, Immunologic
1
2008
27
0.080
Why?
Transcription Factors
2
2023
558
0.080
Why?
Bone and Bones
3
2021
473
0.080
Why?
Lymphocyte Subsets
1
2008
13
0.080
Why?
Immunoglobulin lambda-Chains
1
2008
14
0.080
Why?
Haplotypes
1
2008
83
0.080
Why?
Liver Neoplasms
1
2012
329
0.080
Why?
Granulocyte Colony-Stimulating Factor
1
2008
60
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Gene Deletion
1
2009
267
0.080
Why?
Receptors, Immunologic
1
2008
37
0.080
Why?
Ligands
1
2008
203
0.080
Why?
Neoplastic Stem Cells
1
2009
100
0.080
Why?
Osteogenesis
1
2011
353
0.080
Why?
Twins
1
2007
21
0.070
Why?
Busulfan
1
2007
19
0.070
Why?
Diphosphonates
1
2008
90
0.070
Why?
Immunophenotyping
1
2007
109
0.070
Why?
Herpesviridae Infections
2
2019
53
0.070
Why?
Leukocytes, Mononuclear
1
2007
113
0.070
Why?
Caspases
2
2018
104
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Creatinine
1
2007
140
0.070
Why?
Blood Proteins
1
2007
80
0.070
Why?
Skin Neoplasms
1
2012
489
0.070
Why?
Antibodies, Neoplasm
1
2006
28
0.070
Why?
Immunosuppressive Agents
1
2008
221
0.070
Why?
Graft vs Leukemia Effect
1
2006
2
0.070
Why?
Cohort Studies
3
2020
1400
0.070
Why?
Plasmacytoma
1
2006
39
0.070
Why?
Chromosome Banding
1
2006
24
0.070
Why?
MicroRNAs
1
2010
349
0.070
Why?
Amiloride
1
2005
8
0.070
Why?
HLA-A2 Antigen
1
2005
11
0.070
Why?
Bone Marrow Transplantation
2
2022
112
0.070
Why?
Imaging, Three-Dimensional
2
2017
152
0.060
Why?
Sensitivity and Specificity
1
2007
855
0.060
Why?
Predictive Value of Tests
3
2018
907
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
29
0.060
Why?
Tomography, X-Ray Computed
2
2023
1152
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
4
0.060
Why?
Piperidones
1
2024
5
0.060
Why?
Enoxaparin
1
2004
27
0.060
Why?
Telomere
1
2024
36
0.060
Why?
Retreatment
1
2024
56
0.060
Why?
Ferritins
1
2024
29
0.060
Why?
NF-kappa B
2
2018
315
0.060
Why?
Morpholines
1
2024
67
0.060
Why?
Cost of Illness
1
2024
113
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
78
0.060
Why?
Neoplasms
1
2014
1233
0.060
Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
Why?
DNA, Neoplasm
2
2020
145
0.060
Why?
Epidemiologic Methods
3
2008
49
0.060
Why?
Fibroblasts
1
2005
352
0.060
Why?
Gene Silencing
2
2016
114
0.060
Why?
Cluster Analysis
3
2010
232
0.050
Why?
Cell Communication
1
2023
69
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
47
0.050
Why?
Geography
1
2022
61
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Whole-Body Irradiation
1
2022
129
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Quantitative Trait Loci
1
2022
42
0.050
Why?
Primary Cell Culture
1
2022
61
0.050
Why?
Patient Selection
1
2023
253
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
35
0.050
Why?
Risk
2
2014
313
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Anticoagulants
1
2004
253
0.050
Why?
Phylogeny
1
2022
234
0.050
Why?
Child, Preschool
2
2020
3872
0.050
Why?
Age of Onset
2
2013
108
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Rabbits
2
2013
374
0.050
Why?
Polymorphism, Genetic
1
2022
181
0.050
Why?
Transcriptional Activation
1
2021
118
0.050
Why?
Fibrosis
1
2021
178
0.050
Why?
Edema
1
2021
68
0.050
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
Why?
Cyclin D2
1
2020
20
0.050
Why?
Aneuploidy
1
2020
16
0.050
Why?
Spatio-Temporal Analysis
1
2020
9
0.050
Why?
Base Sequence
1
2022
644
0.050
Why?
Repressor Proteins
1
2022
150
0.050
Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
54
0.040
Why?
Cyclin D1
1
2020
56
0.040
Why?
Genome, Human
1
2021
110
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Protein Kinase Inhibitors
1
2022
205
0.040
Why?
Single-Cell Analysis
1
2020
62
0.040
Why?
Genetic Loci
1
2020
44
0.040
Why?
Mice, Transgenic
1
2021
541
0.040
Why?
False Negative Reactions
1
2019
29
0.040
Why?
Genetic Variation
1
2020
214
0.040
Why?
Incidence
2
2013
982
0.040
Why?
DNA Mutational Analysis
1
2020
176
0.040
Why?
Neoplasm Invasiveness
1
2020
268
0.040
Why?
Europe
1
2019
75
0.040
Why?
Herpesvirus 4, Human
1
2019
39
0.040
Why?
Communicable Disease Control
1
2019
36
0.040
Why?
Computational Biology
1
2020
213
0.040
Why?
RNA, Messenger
2
2016
1101
0.040
Why?
beta 2-Microglobulin
2
2009
38
0.040
Why?
Genome, Viral
1
2019
78
0.040
Why?
Virus Diseases
1
2019
39
0.040
Why?
DNA, Viral
1
2019
133
0.040
Why?
Fibrinogen
1
2018
32
0.040
Why?
Immunoglobulin A
1
2018
45
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
20
0.040
Why?
Bone Marrow Cells
2
2014
190
0.040
Why?
Platelet Count
2
2008
64
0.040
Why?
DNA-Binding Proteins
1
2021
418
0.040
Why?
Pathology, Molecular
1
2018
22
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
Why?
Oncogene Proteins, Fusion
1
2018
56
0.040
Why?
Immunoglobulin G
1
2018
188
0.040
Why?
Data Interpretation, Statistical
2
2010
158
0.040
Why?
Databases, Factual
2
2013
660
0.040
Why?
Child
2
2020
6838
0.040
Why?
Kidney Function Tests
1
2017
49
0.040
Why?
False Positive Reactions
1
2017
60
0.040
Why?
Glomerular Filtration Rate
1
2017
111
0.040
Why?
Lamins
1
2016
5
0.040
Why?
Cell Transformation, Neoplastic
1
2018
180
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
19
0.030
Why?
Internationality
1
2017
41
0.030
Why?
Amino Acid Sequence
1
2018
582
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
75
0.030
Why?
Genes, p53
1
2016
51
0.030
Why?
Glycolysis
1
2016
68
0.030
Why?
Proteolysis
1
2016
93
0.030
Why?
Enzyme Activation
1
2016
273
0.030
Why?
Chromosome Mapping
2
2006
155
0.030
Why?
Prevalence
1
2019
951
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Phosphorylation
1
2016
526
0.030
Why?
Kidney Diseases
1
2017
211
0.030
Why?
Myocardium
1
2017
439
0.030
Why?
Asymptomatic Diseases
1
2014
36
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
Why?
Karyotype
1
2014
17
0.030
Why?
Capsid
1
2014
3
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
7
0.030
Why?
HIV-1
1
2014
53
0.030
Why?
Cerebrospinal Fluid
1
2013
30
0.030
Why?
Homozygote
1
2013
57
0.030
Why?
Genetic Vectors
1
2014
127
0.030
Why?
Nicotinamide Mononucleotide
1
2013
3
0.030
Why?
Acrylamides
1
2013
7
0.030
Why?
Diagnosis, Differential
1
2017
1038
0.030
Why?
Receptors, CXCR4
1
2013
27
0.030
Why?
Niacinamide
1
2013
22
0.030
Why?
Dependovirus
1
2014
103
0.030
Why?
Amides
1
2013
36
0.030
Why?
NAD
1
2013
42
0.030
Why?
Enzyme Induction
1
2013
79
0.030
Why?
Nitriles
1
2013
52
0.030
Why?
Sirtuin 1
1
2013
28
0.030
Why?
Chemokine CXCL12
1
2013
30
0.030
Why?
Gene Knockdown Techniques
1
2013
106
0.030
Why?
Transplantation Chimera
2
2003
15
0.030
Why?
RNA, Small Interfering
1
2013
215
0.030
Why?
Infant
1
2020
3565
0.030
Why?
Piperidines
1
2013
96
0.030
Why?
Induction Chemotherapy
1
2012
60
0.030
Why?
Lymphocyte Count
1
2011
22
0.030
Why?
Acute Disease
1
2013
367
0.020
Why?
HIV Infections
1
2016
353
0.020
Why?
Chemokine CXCL10
1
2011
19
0.020
Why?
Antibodies, Neutralizing
1
2011
65
0.020
Why?
Sex Factors
1
2013
690
0.020
Why?
Pharmacogenetics
1
2011
51
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
25
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
44
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
44
0.020
Why?
Enzyme Inhibitors
1
2013
378
0.020
Why?
Microarray Analysis
1
2010
73
0.020
Why?
International Classification of Diseases
1
2010
63
0.020
Why?
Argonaute Proteins
1
2010
11
0.020
Why?
RNA-Binding Proteins
1
2011
118
0.020
Why?
Oligonucleotides
1
2010
81
0.020
Why?
Polyploidy
1
2009
11
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
57
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Neoplasm Metastasis
1
2009
235
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Serum Albumin
1
2008
58
0.020
Why?
Polyethylene Glycols
1
2008
89
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
548
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
212
0.020
Why?
Age Distribution
1
2007
169
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Recombinant Proteins
1
2008
488
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
81
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
179
0.020
Why?
Brain
1
2013
1313
0.020
Why?
Survivors
1
2006
120
0.020
Why?
Pregnancy
1
2011
2469
0.010
Why?
Probability
1
2003
162
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Administration, Oral
1
2003
432
0.010
Why?
Tissue Donors
1
2003
110
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description